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From January 1981 to December 1990, 2180 patients underwent orthotopic liver transplanta-
tion at the University of Pittsburgh. Thirty-two patients (1.5%) were identified with invasive 
aspergillosis (29 lung, 2 intraabdominal, 1 meningitis). Of 29 patients with invasive lung disease, 
only 23 (79%) had positive culture (Aspergillus /umigatus, 20; Aspergillus jlavus, 3). Forty-eight 
variables were analyzed and compared in 23 patients with invasive disease with positive cultures 
and 9 patients with colonization only. The variables associated with pulmonary invasive disease, 
by univariate analysis, were surgical time (P = .03), presence of laparotomies (P = .02), higher 
creatinine level at time of Aspergillus isolation (P = .01), and use ofOKT3 (P = .02). However, in 
a multivariate analysis, only the last two (creatinine, OKT3) were associated with invasive lung 
aspergillosis. Of 4 patients with positive abdominal wound culture, 2 had local invasive aspergil-
losis. Therefore. positive cultures of Aspergillus organisms from respiratory secretions and 
wound drainage may represent invasive disease and should not be ignored. 
Fungal infections remain an important cause of high mor-
bidity and mortality after orthotopic liver transplantation 
[1-3]. Aspergillosis is the second most important cause of 
fungal infection after candidiasis and is associated with a mor-
tality approaching 100% [1-4]. The significance of isolating 
Aspergillus species from any clinical specimen is still unclear. 
and the distinction between disease and colonization is diffi-
cult. This study assessed the significance of such cultures and 
identified factors associated with the development of inva-
sive lung aspergillosis after liver transplantation. 
Materials and Methods 
Studv population. During a 10-year period from January 
1981 through December 1990. 2180 adults underwent ortho-
topic liver transplantation at Presbyterian University Hospital. 
University of Pittsburgh. Surveillance for fungi was not rou-
tinely done; specimens were usually submitted for culture when 
clinically indicated. All cases after liver transplantation with pos-
itive culture or histology for Aspergillus organisms at any site 
were retrospectively identified from clinical microbiology and 
pathology records. Standard methods of fungal culture and 
identification were used. Histologic sections were stained with 
hematoxylin-eosin. methenamine silver. and occasionally peri-
odic acid-Schiff stains. Septate hyphae with dichotomous 
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branching at 45° angles were considered histologic evidence of 
aspergillosis. The medical records of these cases were reviewed. 
Definitions of invasive aspergillosis and colonization. De-
finitive invasive aspergillosis included patients diagnosed by his-
tology (biopsy or autopsy). Probable invasive aspergillosis in-
cluded patients with a characteristic clinical and radiologic pic-
ture. a culture positive for Aspergillus species. and a lack of 
response to antibacterial therapy [5]. Patients who had positive 
culture with no evidence of invasive disease were classified as 
having colonization. Nosocomial aspergillosis was defined as a 
case that occurred during the patient's hospital stay without evi-
dence of its presence at admission. 
Patient management and immunosuppression. All patients 
underwent orthotopic liver transplant as described by Starzl et 
al. [6]. either with primary anastomosis of the bile duct or with 
Roux-en-Y choledochojejunostomy. Two immunosuppression 
regimens were used. The first included cyclosporine (Sandoz. 
East Hanover. NJ) and steroids. Cyclosporine was initially ad-
ministered intravenously (3 mg/kg/day). Oral cyclosporine was 
begun with the return of bowel function and overlapped with 
the intravenous dose for a short period. Since 1983. cyclospor-
ine has been adjusted to obtain blood levels of800-1 000 ng/mL 
by RIA. An intravenous intraoperative dose of I g of methyl-
prednisolone was followed by a 5-day taper from 200 to 20 mg. 
Azathioprine was also given to some patients. The second regi-
men included the new immunosuppressive agent FK506 (Fuji-
sawa Pharmaceutical. Osaka. Japan) and low-dose steroids (20 
mg/day) starting immediately after transplantation. Rejection 
episodes occurring with either regimen were treated with in-
creased dose of steroids. either a I-g "pulse" dose or a 5-day 
recycle of methylprednisolone. Steroid-resistant rejection was 
treated with intravenous OKT3 monoclonal antibody (Ortho 
Pharmaceuticals. Raritan. NJ). 
Bacterial prophylaxis included intravenous cefotaxime and 
ampicillin (both. 4 g/day) given for 3 days. Fungal prophylaxis 
included oral nystatin (2 million units daily) begun at the time 
of surgery and continued throughout the hospitalization. 
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Factors associated with invasive disease. Forty-eight clinical 
variables were analyzed and compared between patients with 
pulmonary invasive aspergillosis and patients with colonization 
of respiratory secretions with Aspergillus species. Laboratory vari-
ables at day of diagnosis of invasive aspergillosis were compared 
with the same variables at the day of the first positive Aspergillus 
culture in the colonization group. The variables analyzed before 
transplant were age. sex, liver disease. use of steroids and other 
immunosuppressive agents. use of intravenous antibiotics in the 
preceding month, and liver function tests. Intraoperatively ana-
lyzed were cumulative intraoperative time (hours), retransplan-
tation operations. other abdominal operations (laparotomies), 
and total number of blood products given in the operating room. 
Posttransplant variables analyzed were immunosuppressive 
agents (cyclosporine. FK506, azathioprine, OKT3, steroids) 
given. the use and duration of non prophylactic intravenous anti-
biotics. Aspergillus isolation (species, site. time after transplanta-
tion. and association with Candida species). clinical complaints, 
associated infections, presence of diabetes. requirement for he-
modialysis. and laboratory values (levels or counts of total white 
blood cells. polymorphonuclear leukocytes, immature band 
forms. hematocrit. platelets. prothrombin time, partial thrombo-
plastin time. total bilirubin, alkaline phosphatase. aspartate ami-
notransferase [AST], alanine aminotransferase. and serum al-
bumin). 
Statistical analysis. We did univariate logistic analyses to 
identify factors associated with invasive aspergillosis. The likeli-
hood ratio x2 test (two-tailed) was used to assess whether a fac-
tor was associated with invasive disease. On the basis of results 
of the univariate analyses, we did a multivariate logistic analysis. 
Variables were included in the multivariate analysis if they had 
P < .25 or were known to be biologically important. The back-
ward elimination method was used as a variable selection tech-
nique. The likelihood ratio x2 test (two-tailed) was used to assess 
the importance of each factor to the model (i.e., whether a factor 
was to be excluded from the model) [7]. 
Results 
During the IO-year study period, 32 (1.5%) of 2180 liver 
transplant recipients developed invasive aspergillosis. The 
diagnosis was premortem in 19 patients (59%) and postmor-
tem in 13 (41 %). They included 29 patients with pulmonary 
disease (definitive in 21. probable in 8), 2 with definitive 
intraabdominal disease, and I with Aspergillus meningitis 
who was diagnosed at autopsy. In 27 patients the diagnosis 
was done in the initial posttransplant period and in 5 pa-
tients at subsequent admissions. Of these 5 late admissions, 3 
patients were readmitted for retransplantation. All cases but 
I were nosocomial infections. Of the 29 cases with invasive 
pulmonary aspergillosis, 23 (79%) had positive cultures (20 
with Aspergillus fUllligatus. 3 with Aspergillus flavus). The 6 
remaining patients had definitive pulmonary aspergillosis 
with negative cultures in respiratory secretions (21 %). Both 
patients with intraabdominal invasive aspergillosis, had posi-
tive abdominal wound culture (A. JumigafUs). 
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Figure l. Time of occurrence of positive culture for Aspergillus 
organisms in respiratory secretions in 23 patients with invasive 
aspergillosis and 9 with colonization after liver transplantation. In 
invasive group, this time is also time of diagnosis of invasive dis-
ease. 
We subsequently identified II patients who had positive 
Aspergillus cultures without evidence of invasive aspergillosis 
and were never given amphotericin B. They were classified 
as having only colonization. In 9 patients, Aspergillus species 
were isolated from respiratory secretions (A. fumigalUs in 5, 
A. flavus in 2, Aspergillus niger in 2) and in 2 patients from 
abdominal wound drainage (A. fumigatus in both). Nine of 
these patients survived and are still alive with a follow-up 
between 8 months and 8 years. Two patients died with ab-
dominal sepsis at days 27 and 97; invasive aspergillosis was 
not found at autopsy. 
The number of samples submitted for fungal culture in 
patients with invasive aspergillosis was four times higher 
than in patients with colonization (mean, 6 vs. 1.5 samples/ 
patient, respectively). 
Patients with Positive Culture in Respiratory Secretions 
Aspergillus organisms were isolated from the respiratory 
secretions of 32 patients (1.5%). To assess the significance of 
this, we compared 23 patients with invasive lung disease 
(who also had positive culture of respiratory secretions) to 9 
patients with colonization. The two groups were comparable 
with respect to liver disease, sex ratio. and age. There was no 
statistical difference between the time of first positive culture 
and the time of diagnosis of invasive disease (invasive 
group). The median time of diagnosis of invasive disease, 
expressed in days after the first liver transplant operation, 
was 38 days (range, 7-550), and the median time of the first 
positive culture in these patients was 24 days (range, 7-550). 
Figure I shows the time of occurrence of the first pOSitive 
Aspergillus culture in relation to the first transplant operation 
in the two groups. Fifty percent of the patients were diag-
----------._------_. 
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Table 1. Factors associated with invasive disease. univariate analysis, in liver transplant recipients 
with aspergillosis. 
Invasive Odds 
Variable Colonization disease ratio p' 
Surgical time. h 13.7 (7.1) 21.1 (9.6) 1.12 .03 
Additional steroids 33.3 65.2 3.75 .10 
Azathioprine 22.2 52.2 3.82 .12 
Red blood cells. units 19.5 (17.6) 33.7 (25.7) 1.04 .10 
Laparotomies 11.1 52.2 8.73 .02 
Creatinine. mg/dL 2.1 (1.2) 3.7 (1.8) 2.10 .01 
Change in aspartate aminotransferase. 
lUll 0.1 (1.5) 3.7 (1.8) 1.21 .20 
Repeat cycle 11.1 43.5 6.15 .07 
OKT3 monoclonal antibody 22.2 69.6 8.00 .02 
Retransplantation 33.3 60.9 3.11 .16 
Days of antibiotics 10.3 (7.5) 16.7 (14.5) 1.05 .18 
NOTE. Data are mean (SO) or % of patients . 
• p < .05 is significant. based on likelihood ratio x2 test. 
nosed with the disease < I month after transplantation. The 
median time of diagnosis was 1.2 months. Three patients 
were diagnosed >4 months after transplantation. The maxi-
mum follow-up was 80 months. 
Of the 32 patients. 31 had temperature elevations >38°C 
at time of Aspergillus isolation; the exception was a patient in 
the colonization group. 
Univariate analvsis. Table I shows the variables that 
were found by univariate analysis to be associated with inva-
sive disease in the lung. All variables in the table have a 
positive association with invasive disease (i.e .• by increasing 
the level of each factor. we increase the risk of invasive dis-
ease). Four factors were statistically associated (P < .05) with 
invasive disease: cumulative surgical time (hours) before 
diagnosis (P = .028). laparotomies. excluding those done for 
transplantation (P = .024). creatinine level at time of diag-
nosis (P = .015). and OKT3 administration (P = .015). The 
remaining seven variables were not statistically associated 
with invasive disease but either were known to be biologi-
cally important or met the criteria for inclusion in the multi-
variate analysis (i.e .• P < .25). These variables included use 
of additional immunosuppressive agents (steroids. particu-
larly repeat cycles. and azathioprine), multiple transplant 
operations. number of units of red blood cells transfused in 
transplant operations. the increase in AST at time of diagno-
sis relative to the pretransplant value. and the number of 
days intravenous antibiotics were given for treatment of in-
fections (we did not count the number of days intravenous 
antibiotics were given for prophylaxis). 
Mu/til'ariate ana/~DsisK Of the variables that met the crite-
ria for inclusion in the multivariate analysis. one. surgical 
time. is a function oftwo other factors: the number oflaparot-
omies and the number of transplant operations. Because of 
the interrelationships among surgical time. laparotomies. 
and transplant operations. we run the risk of colinearity in 
the multivariate analysis. To avoid this problem. cumulative 
surgical time was analyzed with the exclusion of the number 
of laparotomies and the number of transplant operations 
(model A). These two factors were subsequently analyzed 
with the exclusion of cumulative surgical time (model B). 
The results of the multivariate analyses are presented in 
table 2. Both models show that the use ofOKT3 monoclonal 
antibody is associated with invasive disease. However model 
B's ability to predict invasive disease was inadequate (good-
ness offtt. P = .07). This model was produced when cumula-
tive surgical time was excluded from the multivariate analy-
sis. When the number of laparotomies and the number of 
transplant operations were excluded from the analysis 
(model A). only two variables were associated with invasive 
disease: the use ofOKT3 monoclonal antibody and the creat-
inine level at diagnosis. Neither model identified cumulative 
surgical time or laparotomies and transplant operations as 
being associated with invasive disease. The fact that cumula-
tive surgical time and laparotomies were statistically asso-
Table 2. Results of multivariate analysis ofliver transplant recipi-
ents with aspergillosis. 
Variables Adjusted odds ratio P 
Model A 
Creatinine 1.89 .10 
OKTJ 6.29 .05 
Goodness of fit .37 
Model B 
Units of red blood cells 1.04 .14 
Creatinine 1.96 .OS 
OKTJ S.S3 .05 
Goodness of fi t .07 
NOTE. Model A excludes number of laparotomies and number of 
transplant operations: model B excludes cumulative surgical time. 
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cia ted with invasive disease by univariate analysis but not by 
multivariate analysis suggests that both factors are only surro-
gates of some other factors. A comparison of models A and B 
via the likelihood ratio x2 test indicated that the number of 
units of red blood cells given in the operating room was not 
an important predictor of invasive disease. Lung infiltrates 
were present in all 23 patients with invasive aspergillosis by 
definition but in only 33% of patients colonized. Because one 
of our selection criteria for invasive aspergillosis included 
changes on chest radiography. we excluded this factor from 
our multivariate analysis model. 
Patients with Positive Culture of Wound Drainage 
Four patients had positive Aspergillus culture (A. filllliga-
I/Is) in abdominal wound drainage. They were 3 women and 
I man with a mean age of 38 years. Two of them were only 
colonized with the fungus and survived. Both had bacterial 
peritonitis after a second transplant operation for which they 
received courses of antibiotics. The other 2 developed ab-
dominal invasive disease with Aspergillus species and died. 
Their autopsies did not show lung involvement. In I case 
there was invasion of the diaphragm and suprahepatic ab-
scess. and in the other there was Aspergillus invasion and 
thrombosis of the portal vein. 
Discussion 
In a survey of fungal infections after 101 consecutive liver 
transplants done at our institution. 4 patients were diagnosed 
with invasive aspergillosis and all died secondary to their 
infection [4]. A major obstacle for successful management of 
invasive aspergillosis is the difficulty in establishing early 
diagnosis [8]. Isolation of Aspergillus species from clinical 
specimens ranges between 2?o and 8% in the general popula-
tion [9. 10]. Weiland et al. [II] reported a rate of 3% positive 
respiratory cultures in kidney transplantation. and in the 
current study we found a rate of 1.5% after liver transplanta-
tion. 
[solation of Aspergillus species from respiratory and 
wound specimens does not imply disease. as this fungus may 
be a colonizer or a laboratory contaminant. Although its iso-
lation has otten been ignored. recent studies have shown its 
usefulness as a diagnostic tool in the immunocompromised 
host. Yu et al. [12] observed that positive cultures rarely indi-
cate disease in noncom promised patients but are virtually 
diagnostic of invasive aspergillosis in leukemic patients with 
neutropenia. 
Neutropenic patients are predisposed to Aspergillus pneu-
monia [13]. [n contrast. solid organ transplant patients may 
develop Aspergillus pneumonia without neutropenia. This 
was first shown in kidney transplant recipients. where only a 
high daily dose of steroids but not neutropenia was a predic-
tor of invasive aspergillosis [[4]. In our study. no patient had 
neutropenia at diagnosis of invasive aspergillosis (median 
number ofneutrophils. 7[71/mm: range. 1190-21.716). 
This suggests that defects in neutrophil function. with nor-
mal counts. may also predispose to invasive aspergillosis. 
The value of respiratory isolation of Aspergillus organisms 
atter kidney transplantation has been emphasized by Wei-
land et al. [I I], showing that 45% of patients with positive 
cultures had invasive aspergillosis. In our study. 72% of pa-
tients with respiratory isolation of Aspergillus species and 
50% with positive abdominal wound cultures had invasive 
aspergillosis. This indicates that not only isolation of Asper-
gillus species from respiratory secretions but also isolation 
from wound drainage may represent invasive disease after 
liver transplantation. 
Of 29 patients with invasive pulmonary aspergillosis. 23 
(79%) had positive culture and 6 (21 %) had negative culture. 
This suggests that invasive aspergillosis should be considered 
not only in patients with positive culture but also in high-risk 
patients with negative culture. The issue of fungal prophy-
laxis in such patients is unclear but may be considered. 
We previously found. in a large series of liver transplant 
patients [I]. an association between invasive fungal infection 
and the following variables: longer courses ofnonprophylac-
tic intravenous antibiotics. longer cumulative surgical time 
and higher number of laparotomies. and increased number 
of units of red blood cells transfused. There was also a trend 
between the use of OKT3 and the development of invasive 
fungal infections. It is interesting that the same variables 
were found to be associated with invasive aspergillosis in the 
present series according to univariate analysis. However. the 
only two variables significantly associated with pulmonary 
invasive aspergillosis in our multifactor model were the use 
of OKT3 monoclonal antibody and the creatinine level at 
time of diagnosis. The odds of invasive disease in patients 
who were treated with OKT3 adjusted for creatinine level 
was 6.29 (95% confidence interval. 0.93-42.65) times that of 
patients who did not receive OKT3. Because of the known 
association between CMV infection and OKT3. we exam-
ined the possibility that OKT3 was not directly associated 
with invasive aspergillosis. OKT3 could have been asso-
ciated with a higher rate ofCMV infection (symptomatic or 
asymptomatic) and indirectly associated with aspergillosis. 
We did not find any association between the use of OKT3 
and CMV infection or an association between CMV infec-
tion and invasive aspergillosis. Therefore. we concluded that 
OKT3 was an independent factor associated with invasive 
aspergillosis. 
OKT3 is known to affect circulating T cells by blocking 
their function through interaction with the T cell receptor 
[15]. T cell immunity is an important host defense mecha-
nism against fungal infections such as cryptococcosis. histo-
plasmosis. and coccidioidomycosis. In contrast. it is thought 
that neutrophils and macrophages are the main defense 
mechanism against aspergillosis (16]. Recent reports show 
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that AIDS patients may also develop invasive aspergillosis 
[5. 17]. It has been demonstrated that AIDS patients can 
have leukocyte and macrophage dysfunction without neutro-
penia or corticosteroid intake. It has been suggested that the 
abnormal T cell function in AIDS patients leads to neutro-
phil and macrophage impairment [18]. It is possible that in 
liver transplant recipients. OKT3. by reducing T cell immu-
nity. increases further the impairment ofleukocyte and mac-
rophage function already caused by chronic corticosteroid 
treatment and raises the risk of invasive aspergillosis. 
Cuervas-Mons et a1. [19] demonstrated that pretransplant 
serum creatinine level was the best short-term prognostic 
value in liver transplantation. In our model. we found that 
higher serum creatinine level at time of diagnosis was signifi-
cantly associated with invasive disease. Serum creatinine 
level may reflect the overall clinical status after liver trans-
plantation. and a higher creatinine level may select patients 
with a complicated course who may be more likely to de-
velop invasive aspergillosis. 
Previous studies have shown that two or more positive cul-
tures for Aspergillus species can discriminate between disease 
and colonization [9. 20]. We could not do the same analysis 
here. The limitation of our study was in the fact that the 
respiratory cultures were not taken routinely but only when 
there was clinical indication. This creates a bias. as patients 
with a more severe clinical picture would have had a higher 
chance to be sampled than asymptomatic patients. This ex-
plains the higher number of fungal cultures submitted to the 
laboratory for patients with invasive aspergillosis in this 
study. Since this was a retrospective study. we had no control 
on such potential bias. 
We and others have observed [1-4] that the use of non pro-
phylactic intravenous antibiotics increases the risk of fungal 
infection after liver transplantation. Although this factor was 
included in the multivariate analysis. it was not statistically 
associated with invasive aspergillosis. This suggests that after 
solid organ transplantation. the impairment of innate host 
immune responses are more important than the length of 
antibiotic treatment in predicting invasive aspergillosis [11]. 
In summary. positive cultures for Aspergillus species after 
liver transplantation should never be ignored. as frequently 
they indicate invasive disease. We suggest the following ap-
proach to management in patients with positive Aspergillus 
cultures of respiratory secretions after liver transplantation: 
A patient with chest radiography abnormalities should be 
started on amphotericin B without delay. At the same time. 
further diagnostic procedures should be done to obtain tissue 
specimens for confirmation of invasive aspergillosis. In some 
cases. in patients who have received OKT3 and who have 
high creatinine levels. invasive aspergillosis should be consid-
ered even without positive culture. Each case should be as-
sessed separately. but the use of empiric amphotericin Bin 
some cases does not seem unwise. Patients with positive 
Aspergillus wound culture should be investigated for local 
invasion and should not be assumed to be just colonized 
with the fungus. 
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